Scientific Opinion on the substantiation of a health claim related to thiamin and maintenance of normal neurological development and function pursuant to Article 14 of Regulation (EC) No 1924/2006

Tabs

Article
Panel on Dietetic Products, Nutrition and Allergies
Acknowledgements

The Panel wishes to thank the members of the Working Group on Claims for the preparatory work on this scientific opinion: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Marina Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen.

EFSA Journal
EFSA Journal 2011;9(2):1980 [8 pp.].
doi
10.2903/j.efsa.2011.1980
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen.
Contact
Type
Opinion of the Scientific Committee/Scientific Panel
On request from
the Competent Authority of Germany following an application by HiPP GmbH
Question Number
EFSA-Q-2009-00455
Adopted
28 January 2011
Published
10 February 2011
Affiliation
European Food Safety Authority (EFSA), Parma, Italy
Note
Abstract

Following an application from HiPP GmbH submitted pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the Panel on Dietetic Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a health claim related to thiamin and maintenance of normal neurological development and function. Thiamin is a well recognised nutrient and is measurable in foods by established methods. Thiamin is considered to be sufficiently characterised. Maintenance of normal neurological development and function is considered to be a beneficial physiological effect. It is well recognised that the clinical signs of thiamin deficiency include mental changes, such as apathy, decrease in short-term memory, confusion and irritability as well as polyneuritis and paralysis of the peripheral nerves. All essential nutrients, including vitamins and minerals, are required for normal development of infants and children. The Panel concludes that a cause and effect relationship has been established between the dietary intake of thiamin and maintenance of normal neurological development and function. The following wording reflects the scientific evidence: “Thiamin contributes to the maintenance of normal neurological development and function.” The target population is infants and children up to 3 years.

Keywords
Thiamin, infants, children, neurological function, development, health claims.
Print on demand
Number of Pages
8